BACKGROUND: Glomerular podocyte molecules are involved in the pathogenesis of congenital nephrotic syndrome. However, their role in primary nephrotic syndrome is not clear. This study investigated the expression of nephrin, podocin and synaptopodin in primary nephrotic syndrome. METHODS: Eighty-seven patients with primary nephrotic syndrome including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN) and membranoproliferative glomerulonephritis Type I (MPGN) were included in the study. Glomerular expression of nephrin, podocin and synaptopodin was studied in renal biopsies by immunofluorescence and immunohistochemistry. Correlation of expression with clinical and biochemical parameters was performed. RESULTS: The pattern of expression for all podocyte proteins in controls was uniform fine granular along the capillary walls towards the visceral epithelial cell aspect. Glomerular expression of nephrin was present in all renal biopsies and was similar to that in controls. Glomerular synaptopodin expression was seen in all MN and MPGN patients, while it was seen in 74 % (17/23) MCD and 93.5 % (29/31) FSGS. Reduced synaptopodin expression showed no correlation with clinical and biochemical factors. Podocin expression was present in 5/23 MCD (22 %), 3/31 FSGS (9.6 %), 13/17 MN (76.4 %) and 13/16 MPGN (81 %) patients. The reduced expression of podocin significantly correlated with the degree of proteinuria (p = 0.032). No correlation with age, gender and serum creatinine level was observed. CONCLUSION: Reduction of glomerular podocin expression found in MCD and FSGS is related to the amount of proteinuria. Our findings suggest that alteration in podocyte phenotype may not be a primary event and may reflect the degree of podocyte injury in primary nephrotic syndrome.
BACKGROUND: Glomerular podocyte molecules are involved in the pathogenesis of congenital nephrotic syndrome. However, their role in primary nephrotic syndrome is not clear. This study investigated the expression of nephrin, podocin and synaptopodin in primary nephrotic syndrome. METHODS: Eighty-seven patients with primary nephrotic syndrome including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN) and membranoproliferative glomerulonephritis Type I (MPGN) were included in the study. Glomerular expression of nephrin, podocin and synaptopodin was studied in renal biopsies by immunofluorescence and immunohistochemistry. Correlation of expression with clinical and biochemical parameters was performed. RESULTS: The pattern of expression for all podocyte proteins in controls was uniform fine granular along the capillary walls towards the visceral epithelial cell aspect. Glomerular expression of nephrin was present in all renal biopsies and was similar to that in controls. Glomerular synaptopodin expression was seen in all MN and MPGNpatients, while it was seen in 74 % (17/23) MCD and 93.5 % (29/31) FSGS. Reduced synaptopodin expression showed no correlation with clinical and biochemical factors. Podocin expression was present in 5/23 MCD (22 %), 3/31 FSGS (9.6 %), 13/17 MN (76.4 %) and 13/16 MPGN (81 %) patients. The reduced expression of podocin significantly correlated with the degree of proteinuria (p = 0.032). No correlation with age, gender and serum creatinine level was observed. CONCLUSION: Reduction of glomerular podocin expression found in MCD and FSGS is related to the amount of proteinuria. Our findings suggest that alteration in podocyte phenotype may not be a primary event and may reflect the degree of podocyte injury in primary nephrotic syndrome.
Authors: Jaakko Patrakka; Vesa Ruotsalainen; Ilkka Ketola; Christer Holmberg; Markku Heikinheimo; Karl Tryggvason; Hannu Jalanko Journal: J Am Soc Nephrol Date: 2001-02 Impact factor: 10.121
Authors: S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi Journal: Am J Pathol Date: 2001-05 Impact factor: 4.307
Authors: Klaas Koop; Michael Eikmans; Hans J Baelde; Hiroshi Kawachi; Emile De Heer; Leendert C Paul; Jan A Bruijn Journal: J Am Soc Nephrol Date: 2003-08 Impact factor: 10.121
Authors: Ning He; Alireza Zahirieh; Yan Mei; Brian Lee; Sean Senthilnathan; Betty Wong; Bettina Mucha; Friedhelm Hildebrandt; David E Cole; Daniel Cattran; York Pei Journal: Clin J Am Soc Nephrol Date: 2006-10-25 Impact factor: 8.237
Authors: U Lenkkeri; M Männikkö; P McCready; J Lamerdin; O Gribouval; P M Niaudet; K Antignac C; C E Kashtan; C Homberg; A Olsen; M Kestilä; K Tryggvason Journal: Am J Hum Genet Date: 1999-01 Impact factor: 11.025
Authors: Stephen J Tonna; Alexander Needham; Krishna Polu; Andrea Uscinski; Gerald B Appel; Ronald J Falk; Avi Katz; Salah Al-Waheeb; Bernard S Kaplan; George Jerums; Judy Savige; Jennifer Harmon; Kang Zhang; Gary C Curhan; Martin R Pollak Journal: BMC Nephrol Date: 2008-09-29 Impact factor: 2.388
Authors: Ali H El-Far; Mohamed A Lebda; Ahmed E Noreldin; Mustafa S Atta; Yaser H A Elewa; Mohamed Elfeky; Shaker A Mousa Journal: Int J Mol Sci Date: 2020-06-18 Impact factor: 5.923
Authors: Lívia Helena de Morais Pereira; Crislaine Aparecida da Silva; Maria Luíza Gonçalves Dos Reis Monteiro; Liliane Silvano Araújo; Laura Penna Rocha; Marcelo Bernardes da Rocha Reis; Fernando Silva Ramalho; Rosana Rosa Miranda Corrêa; Marcos Vinicius Silva; Marlene Antonia Reis; Juliana Reis Machado Journal: PLoS One Date: 2019-06-12 Impact factor: 3.240
Authors: Daniel F Arruda-Junior; Flavia L Martins; Rafael Dariolli; Leonardo Jensen; Ednei L Antonio; Leonardo Dos Santos; Paulo J F Tucci; Adriana C C Girardi Journal: Front Physiol Date: 2016-07-12 Impact factor: 4.566